303 related articles for article (PubMed ID: 25234198)
21. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
22. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.
Kim SY; Kim BW; Pyo JY; Hong SW; Chang HS; Park CS
World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
24. Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study.
Nam IC; Park JO; Joo YH; Cho KJ; Kim MS
Head Neck; 2013 Jan; 35(1):40-5. PubMed ID: 22266805
[TBL] [Abstract][Full Text] [Related]
25. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.
Koo BS; Choi EC; Park YH; Kim EH; Lim YC
J Am Coll Surg; 2010 Jun; 210(6):895-900. PubMed ID: 20510797
[TBL] [Abstract][Full Text] [Related]
26. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
Vergez S; Sarini J; Percodani J; Serrano E; Caron P
Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
[TBL] [Abstract][Full Text] [Related]
27. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
Back K; Choe JH; Kim JS; Kim JH
Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
[TBL] [Abstract][Full Text] [Related]
28. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
29. Papillary thyroid cancer: the value of bilateral diagnostic lymphadenectomy.
Bhangu JS; Bichler C; Altmeier J; Hargitai L; Selberherr A; Mazal P; Brugger J; Scheuba C; Riss P; Niederle B
Langenbecks Arch Surg; 2022 Aug; 407(5):2059-2066. PubMed ID: 35301585
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
32. Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.
Lim YC; Liu L; Chang JW; Koo BS
Oral Oncol; 2016 Nov; 62():109-113. PubMed ID: 27865362
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract][Full Text] [Related]
37. Is level IIb lymph node dissection always necessary in N1b papillary thyroid carcinoma patients?
Lee J; Sung TY; Nam KH; Chung WY; Soh EY; Park CS
World J Surg; 2008 May; 32(5):716-21. PubMed ID: 18087766
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.
Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2007 Nov; 31(11):2085-91. PubMed ID: 17885787
[TBL] [Abstract][Full Text] [Related]
39. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
40. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?
Calò PG; Pisano G; Medas F; Marcialis J; Gordini L; Erdas E; Nicolosi A
World J Surg Oncol; 2014 May; 12():152. PubMed ID: 24885654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]